Proceedings Article | 4 March 2019
KEYWORDS: Microscopy, Multimodal imaging, Inflammation, Lung, In vivo imaging, Confocal microscopy, Patents, Luminescence, Mouse models, Antimicrobial agents
As I'm currently held by a confidentiality agreement regarding our latest data (towards patent and manuscript submission), I cannot submit a paper at this point. Please kindly refer to our most recently published work on the topic:
Liesbeth Vanherp, Jennifer Poelmans, Amy Hillen, Kristof Govaerts, Sarah Belderbos, Tinne Buelens, Katrien Lagrou, Uwe Himmelreich, Greetje Vande Velde. Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice. Scientific Reports, 2018, 14; 8(1): 3009.
Jennifer Poelmans, Uwe Himmelreich, Liesbeth Vanherp, Luca Zhai, Amy Hillen, Bryan Holvoet, Sarah Belderbos, Matthias Brock, Johan Maertens, Greetje Vande Velde*, Katrien Lagrou*. A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy [accepted, 2018]
Vande Velde G, Kucharíková S, Van Dijck P, Himmelreich U. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms. Int J Antimicrob Agents. 2018 [Epub ahead of print]
